1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): Bladder Cancer. National Comprehensive Cancer Network; 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf. Accessed February 16, 2023.
2. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3. Systematic literature review (SLR) and network meta-analysis (NMA) of first-line therapies (1L) for locally advanced/metastatic urothelial carcinoma (la/mUC).
4. Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial.
5. Food and Drug Administration. Successes and Opportunities in Modeling and Simulation for FDA. Food and Drug Administration; 2022.